Bottom line
SCHF vs IXUS: the short answer
SCHF (Schwab International Equity ETF) and IXUS (iShares Core MSCI Total International Stock ETF) share a meaningful slice of their top holdings — about 67% by weight.
But IXUS is far broader, holding 4,530 positions to 1,479 for SCHF, so beyond the top names it adds exposure SCHF doesn't have.
SCHF is cheaper at 0.03% vs 0.07% — a difference of $4.00 a year per $10,000 invested.
Over five years, SCHF returned +5.0% a year vs +4.2% for IXUS.
Updated Nov 19, 2026
SCHF vs IXUS side by side
| SCHF | IXUS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Schwab | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.03% | 0.07% |
| Annual cost per $10k | $3 | $7 |
| 10-yr cost on $10k (prospectus) | $39 | $90 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +3.5% | +5.1% |
| 5-yr return (annualized) | +5.0% | +4.2% |
| 10-yr return (annualized) | +5.4% | +5.0% |
| Best quarter | +17.0% | +17.2% |
| Worst quarter | −23.1% | −24.1% |
| Net assets (fund) | $66.5B | $58.4B |
| Number of holdings | 1,479 | 4,530 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SCHF | IXUS | Difference |
|---|---|---|---|
| 2024 | +3.5% | +5.1% | −1.7% |
| 2023 | +18.3% | +15.6% | +2.7% |
| 2022 | −14.9% | −16.4% | +1.5% |
| 2021 | +11.4% | +8.5% | +2.9% |
| 2020 | +9.9% | +11.1% | −1.3% |
| 2019 | +22.2% | +21.9% | +0.3% |
| 2018 | −14.4% | −14.5% | +0.2% |
| 2017 | +25.8% | +28.1% | −2.3% |
| 2016 | +2.9% | +4.7% | −1.8% |
| 2015 | −2.4% | −4.6% | +2.2% |
Source: Fund prospectus bar charts
Holdings overlap
18 of SCHF's top 25 holdings also appear in IXUS's top 25.
| Holding | SCHF | IXUS |
|---|---|---|
| Samsung Electronics Co Ltd | 3.32% | 1.92% |
| SK hynix Inc | 2.81% | 1.48% |
| ASML Holding NV | 2.10% | 1.51% |
| HSBC Holdings PLC | 1.08% | 0.86% |
| Roche Holding AG | 0.99% | 0.72% |
| Novartis AG | 0.97% | 0.68% |
| AstraZeneca PLC | 0.93% | 0.60% |
| Royal Bank of Canada | 0.90% | 0.69% |
| Nestle SA | 0.88% | 0.60% |
| Shell PLC | 0.80% | 0.60% |
| Mitsubishi UFJ Financial Group Inc | 0.69% | 0.56% |
| Commonwealth Bank of Australia | 0.66% | 0.49% |
| Toronto-Dominion Bank/The | 0.64% | 0.47% |
| Sap Se | 0.62% | 0.45% |
| Banco Santander SA | 0.61% | 0.48% |
Source: SEC Form N-PORT
SCHF top 10
- Samsung Electronics Co Ltd — 3.32%
- SK hynix Inc — 2.81%
- ASML Holding NV — 2.10%
- HSBC Holdings PLC — 1.08%
- Roche Holding AG — 0.99%
- Novartis AG — 0.97%
- AstraZeneca PLC — 0.93%
- Royal Bank of Canada — 0.90%
- Nestle SA — 0.88%
- Shell PLC — 0.80%
IXUS top 10
- Taiwan Semiconductor Manufacturing Company Limited — 4.29%
- Samsung Electronics Co., Ltd. — 1.92%
- ASML Holding N.V. — 1.51%
- SK hynix Inc. — 1.48%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.41%
- Tencent Holdings Limited — 0.88%
- Hsbc Holdings Plc — 0.86%
- Roche Holding AG — 0.72%
- Royal Bank Of Canada — 0.69%
- Novartis AG — 0.68%
FAQ
What is the difference between SCHF and IXUS?
Which is cheaper, SCHF or IXUS?
Should I own both SCHF and IXUS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.